Please Note: This trial is no longer enrolling new participants
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients with Refractory Advanced/Metastatic Colorectal Cancer (FRUITION)
| Protocol No. | CTO-CCR-AGICC-FRUQ-004 | Scope | National |
|---|---|---|---|
| Principal Investigator | Anita Turk | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase II |
